Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PTH(1-34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS Trial.
Palermo A, Mangiameli G, Tabacco G, Longo F, Pedone C, Briganti SI, Maggi D, Vescini F, Naciu A, Lauria Pantano A, Napoli N, Angeletti S, Pozzilli P, Crucitti P, Manfrini S. Palermo A, et al. J Clin Endocrinol Metab. 2016 Nov;101(11):4039-4045. doi: 10.1210/jc.2016-2530. Epub 2016 Aug 15. J Clin Endocrinol Metab. 2016. PMID: 27525532 Clinical Trial.
Vitamin K and osteoporosis: Myth or reality?
Palermo A, Tuccinardi D, D'Onofrio L, Watanabe M, Maggi D, Maurizi AR, Greto V, Buzzetti R, Napoli N, Pozzilli P, Manfrini S. Palermo A, et al. Metabolism. 2017 May;70:57-71. doi: 10.1016/j.metabol.2017.01.032. Epub 2017 Feb 4. Metabolism. 2017. PMID: 28403946 Review.
Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D'Onofrio L, Briganti SI, Castellitto D, Casini A, Pedone C, Lelli D, Fabbri A, Bilezikian JP, Napoli N, Pozzilli P, Manfrini S, Cesareo R. Palermo A, et al. J Clin Endocrinol Metab. 2020 Jul 1;105(7):dgaa174. doi: 10.1210/clinem/dgaa174. J Clin Endocrinol Metab. 2020. PMID: 32271382
Selenium: A Trace Element for a Healthy Skeleton - A Narrative Review.
Vescini F, Chiodini I, Palermo A, Cesareo R, De Geronimo V, Scillitani A, Gennari L, Falchetti A. Vescini F, et al. Among authors: palermo a. Endocr Metab Immune Disord Drug Targets. 2021;21(4):577-585. doi: 10.2174/1871530320666200628030913. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 32600242 Review.
Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.
Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, Langdahl B. Tsourdi E, et al. Among authors: palermo a. J Clin Endocrinol Metab. 2020 Oct 26:dgaa756. doi: 10.1210/clinem/dgaa756. Online ahead of print. J Clin Endocrinol Metab. 2020. PMID: 33103722
574 results